Abstract
Proliferation and migration of vascular smooth muscle cells (VSMC) are important in the development and/or progression of many cardiovascular diseases, including atherosclerosis. Evidence shows that matrix metalloproteinase (MMP)-2 and MMP-9 are related to the pathogenesis of atherosclerosis. The expressions of MMP-2 and MMP-9 in atherosclerosis are regulated via various pathways, such as p38 mitogen activated protein kinase (MAPK), extracellular signal regulated kinase 1 and 2 (ERK1/2), Akt, and nuclear factor kappa (NF-κB). Di(2-ethylhexyl) phthalate (DEHP) has been shown to induce atherosclerosis by increasing tumor necrosis factor (TNF)-α, interleukin (IL)-6, and intercellular adhesion molecule (ICAM) productions. However, whether DEHP poses any effects on MMP-2 or MMP-9 expression in VSMC has not yet been answered. In our studies, rat aorta VSMC was treated with DEHP (between 2 and 17.5 ppm) and p38 MAPK, ERK1/2, Akt, NF-κB, and MMP-2 and MMP-9 proteins and activities were measured. Results showed that the presence of DEHP can induce higher MMP-2 and MMP-9 expression than the controls. Similar results on MMP-regulating proteins, i.e., p38 MAPK, ERK1/2, Akt, and NF-κB, were also observed. In summary, our current results have showed that DEHP can be a potent inducer of atherosclerosis by increasing MMP-2 and MMP-9 expression at least through the regulations of p38 MAPK, ERK1/2, Akt, and NF-κB.
Highlights
Proliferation and migration in smooth muscle cells (SMC) are known to involve formation of atherosclerosis [1]
Some research showed that Di(2-ethylhexyl) phthalate (DEHP) at concentrations more than 10 and 25 μM induced mouse Leydig cells cytotoxicity [15] and apoptosis in rat hepatocytes [12], respectively, no similar results have been reported in SMC or vascular smooth muscle cells (VSMC)
DEHP at dosage of 3.5 ppm is considered as a safe dose for an adult in general aspects, our results indicated that it is able to induce the expression of matrix metalloproteinase (MMP)-9 noticeably
Summary
Proliferation and migration in smooth muscle cells (SMC) are known to involve formation of atherosclerosis [1]. MMP-2 expression in vascular smooth muscle cells (VSMC) has been linked to several pathological situations, in atherosclerotic plaques, which suggesting a pathogenic role for MMP-2 in the progression of atherosclerosis [4]. The activities as well as expression of MMP-2 and MMP-9 were measured by MMP activity ELISA kits and Western blotting, respectively. Their possible regular pathways, e.g., p38 MAKP, ERK1/2, Akt, and NF-κB, were all analyzed after the treatment of DEHP
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.